Dr. David Gerber responds to reader's question: What are the major factors affecting early graft function in renal transplantation?
What is the recommendation regarding the active use of marijuana in a patient with a history of substance abuse?
The incidence of cardiovascular disease in kidney transplant recipients is nearly twice that in the general population.
What are the important differences between outcomes for patients with acute hepatic failure receiving living-donor vs deceased-donor liver transplants?
Find strategies to minimize this emerging threat in the vulnerable population of solid organ transplant recipients.
Is there any evidence for use of parenteral ganciclovir for prophylaxis against cytomegalovirus (CMV) infection in high-risk patients, especially when the oral formulation is not available?
Get updated on the latest means of prevention and treatment of biliary complications, a major source of morbidity after liver transplantation.
Is laparoscopic sleeve gastrectomy a safe and effective way to get obese patients ready for kidney transplantation?
A renal transplant patient who was switched from azathioprine to mycophenolate mofetil (MMF) a few weeks ago (because of gout requiring permanent treatment with allopurinol), recently had mild, but clinically overt acute pancreatitis.
Why does tacrolimus reverse ongoing acute rejection (even in refractory cases), whereas even high-dose cyclosporine does not?
Is it justified to select HCV-positive donors for pancreas transplantation?
Although I am a physician (in general primary care), I am also a transplant patient. I had a previous transplant from 1983 to 1995. I now have a 5-year-old second kidney transplant, which seems to be suffering chronic rejection.
Transplantation of cultured human islet allografts results in reproducible insulin independence in all subjects under this regimen, comparable to that of the Edmonton protocol.
In this video blog Ron Shapiro, MD discusses emerging data on the proteasome inhibitor bortezomib, a chemotherapeutic agent that targets plasma cells, for treatment of humoral rejection.
How much does it cost to prepare to donate a kidney?
What are the most common psychological disorders after live kidney donation?
How much does chronic exposure to cigarette smoke impact donor lung status?
September is National Cholesterol Education Month. The NCEP is pleased to present the 2005 National Cholesterol Education Month Kit online.
Recognizing that transplantation of nonhuman live cells presents a risk of introducing infectious diseases into the human population, the Food and Drug Administration's Center for Biologics Evaluation and Research initiated a Xenotransplantation Action Plan.
In this video blog, Ron Shapiro, MD, University of Pittsburgh, discusses a new study which suggests that we can continue to explore regimens that involve steroid avoidance after renal transplantation.